Leptin in the regulation of energy balance;La leptina en la regulación del balance energético

Nutricion Hospitalaria

Volumn 17, Issue SUPPL. 1, 2002, Pages 42-48

  Bulló Bonet, Mónica ^a  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

Endocrinology; Leptin; Neuropeptides; Obesity

Indexed keywords

LEPTIN;

ARTICLE; DRUG EFFICACY; DRUG SAFETY; ENERGY BALANCE; HORMONAL REGULATION; HORMONE ACTION; HUMAN; OBESITY; PATHOGENESIS; SIDE EFFECT;

ANIMALS; ENERGY METABOLISM; FATS; HUMANS; LEPTIN;

ANIMALIA;

EID: 17344380797     PISSN: 02121611     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (92)

1. The search for human obesity genes
2. Obesity
3. The regulation of body weight
4. The regulation of body weight: Evidence and clinical implications
5. Dietary fat, carbohydrate balance and weight maintenance: Effect of exercise
6. The role of depot fat in the hypothalamic control of food intake in the rat
7. Insulin and the set-point regulation of body weight
8. Feast and famine: Critical role of glucocorticoids with insulin in daily energy flow
9. Positional cloning of the mouse obese gene and its human homologue
10. Modulation of obese gene expression in rat brown and white adipose tissues
11. Synthesis of leptin in human placenta
12. The stomach is a source of leptin
13. Leptin secretion from adipose tissue in women. Relationship to plasma levels and gene expression
14. Effects of the obese gene product on body weight regulation in ob/ob mice
15. Identification and expression cloning of a leptin receptor OB-R
16. The role of neuropeptide Y in the antiobesity action of the obese gene product
17. Congenital leptin deficiency is associated with severe early-onset obesity in humans
18. A leptin missense mutation associated with hypogonodadism and morbid obesity
19. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
20. Effects of recombinant leptin therapy in a child with congenital leptin deficiency
21. Cerebroespinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans
22. Dcreased cerebroespinal-fluid/serum leptin ratio in obesity: A possible mechanism for leptin resistance
23. Relatively low plasma leptin concentrations precede weight gain in Pima Indians
24. Cord blood leptin is associated with size at birth and predicts infancy weight gain in humans
25. Recombinant leptin for weight loss in obese and lean adults. A randomized, controlled, dose-escalation trial
26. CSF leptin levels after exogenous administration of recombinant methionyl human leptin
27. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. V: Rising eptin levels may signal onset of puberty
28. Human leptin enhances activation and proliferation of human circulating T lymphocytes
29. Biological action of leptin as an angiogenic factor
30. Leptin can induce proliferation, differentiation, and functional activation of hematopoietic cells
31. Leptin activates distinct projections from the dorsomedial and ventromedial hypothalamic nuclei
32. Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels
33. Leptin sensitive neurons in the hypothalamus
34. The central regulation of energy homeostasis: Role of neuropeptide Y and other brain peptides
35. The role of neuropeptide Y in the antiobesity action of the obese gene product
36. Increased neuiropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse
37. Hypothalamic neuropeptide Y, galanin, and amines: Concepts of coexistence in relation to feeding behavior
38. Neuropeptide Y chronically injected into the hypothalamus: A powerful neurochemical inducer of hyperphagia and obesity
39. Neuropeptide regulation of appetite and weight
40. Effects of intrecerebroventricular injection of neuropeptide Y ion energy metabolism
41. Rohner-Jeanrenaud F y Jeanrenaud B Chronic intrecerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity
42. Food deprivation and hypothalamic neuropeptide gene expression: Effects of strain background and the diabetes mutation
43. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y
44. The melanocortin receptors: Agonists, antagonists, and the hormonal control of pigmentation
45. Leptin increases hypothalamic proopiomelanocortin (POMC) mRNA expresion in the rostral arcuate nucleus
46. Localization of the melanocortina-4 receptor (MCR-4) in neuroendocrine and autonomic control circuits in the brain
47. Targeted disruption of the melanocortin-4 receptor results in obesity mice
48. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome
49. Hypothalamic expression of ART, a novel gene related to agouti, is upregulated in obese and diabetic mutant mice
50. Expression of the functional leptin receptor m RNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion
51. Leptin: A potent inhibitor of insulin secretion
52. Acute stimulation of glucose metabolism mice by leptin treatment
53. Direct antidiabetic effect of leptin throught triglyceride depletion of tissues
54. Obese gene expression alters the ability of 30A5 preadipocytes to respond to lipogenic hormones
55. In vitro lipolytic effect of leptin on mouse adipocytes. Evidence for a possible autocrine/paracrine role of leptin
56. Presence of leptin receptors in rat small intestine and leptin effcet on sugar absortion
57. Central leptin modulates behavioral and neural responsivity to CCK
58. Gastric leptin
59. Cholecystokinin and leptin act synergistically to reduce body weight
60. Leptin in gastroprotection induced by cholecystokinin or by a meal. Role of vagal and sensory nerves and nitric oxide
61. Leptin
62. Regulation of energy storage, intake and expenditure
63. Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake
64. Pharmacologic manipulation of ob expression in a dietary model of obesity
65. Plasma leptin and insilun relatinships in obese and nonobese humans
66. Augmented expression of the obese gene in the adipose tissue from rats fed high-fat diet
67. SR59230A blocks beta3-adrenoceptor-linked modulation of uncoupling protein1 and leptin in rat brown adipocytes
68. Effect of a beta3-adrenergic agonist on liver glucokinase gene expression in alloxan-diabetic rats
69. Leptin: In search of role(s) in human physiology and pathophysiology
70. Effects of tumor necrosis factor alpha on leptin secretion and gene expression: Relationship to changes of glucose metabolism in isolated adipocytes
71. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects
72. Sexual dimorphism in plasma lepin concentration
73. Leptin concentrations, sex hormones, and cortisol in nondiabetic men
74. Plasma leptin levels and body fat distribution
75. The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaneous adipose tissue
76. Nocturnal raise of leptin in lean, obese and non-insulin-dependent diabetes mellitus subjects
77. Acute and chronic effect of insulin on leptin production in humans
78. Insulin and leptin: Dual adiposity signals to the brain for the regulation of food intake and body weight
79. Transient increase in obese gene expression after food intake or insulin administration
80. Acute and chronic effect of insulin on leptin production in humans
81. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat
82. Is leptin an insulin counter-regulatory hormone
83. Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action on insulin secretion
84. + channels in pancreatic beta-cells
85. Leptin affects pancreatic endocrine functions throught the sympathetic nervous system
86. Modulation of insulin activities by leptin
87. Negative regulation of peroxisome proliferator-activated receptor-γ gene expression contributes to the adipogenic effect of tumor necrosis factor-α
88. Regulation of leptin promoter function by Sp1, C/EBP, and a novel factor
89. Plasma concentrations of soluble TNF-alpha receptors in obese subjects
90. Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance
91. Relationship between plasma leptin levels and the tumor necrosis factor-α system in obese subjects
92. Autocrine inhibition of leptin production by tumor necrosis factor-α (TNF-α) type-1 receptor in vivo